Snakebite conference - from science to society

21-22 June 2018

Share this article:

Dr John McCafferty (CEO) and Dr Aneesh Karatt-Vellatt will be presenting IONTAS' contribution towards developing safer and more efficacious treatments for snake bites, a major healthcare concern that affects millions of people around the globe.

Using expertise in antibody engineering and phage display technology, IONTAS has generated recombinant anti-venoms based on oligoclonal mixtures of fully human antibodies.